Dual Antiviral Therapy for Persistent Coronavirus Disease 2019 and Associated Organizing Pneumonia in an Immunocompromised Host | Zendy

Caitlin A. Trottier | Zendy; Beverly Wong | Zendy; Rakhi Kohli | Zendy; Cassidy Boomsma | Zendy; Francis Magro | Zendy; Sucharita Kher | Zendy; Christina Anderlind | Zendy; Yoav Golan | Zendy

Open Access

Dual Antiviral Therapy for Persistent Coronavirus Disease 2019 and Associated Organizing Pneumonia in an Immunocompromised Host

Author(s) -

Caitlin A. Trottier,

Beverly Wong,

Rakhi Kohli,

Cassidy Boomsma,

Francis Magro,

Sucharita Kher,

Christina Anderlind,

Yoav Golan

Publication year - 2022

Publication title -

clinical infectious diseases

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.44

H-Index - 336

eISSN - 1537-6591

pISSN - 1058-4838

DOI - 10.1093/cid/ciac847

Subject(s) - medicine , pneumonia , coronavirus , viral pneumonia , covid-19 , immunology , viral shedding , antiviral therapy , disease , virology , respiratory disease , virus , infectious disease (medical specialty) , lung , chronic hepatitis

The management of patients with prolonged viral shedding and coronavirus disease 2019 symptoms remains unclear. Combining antivirals, as practiced in other infections, is theoretically advantageous. We present a case of persistent, symptomatic severe acute respiratory syndrome coronavirus 2 infection and associated organizing pneumonia that was successfully treated with an extended course of combination antiviral therapy.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research